These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12531358)

  • 81. Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses.
    Liu LJ; Watabe S; Yang J; Hamajima K; Ishii N; Hagiwara E; Onari K; Xin KQ; Okuda K
    Vaccine; 2001 Oct; 20(1-2):42-8. PubMed ID: 11567744
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Delivery of antigens used for vaccination: recent advances and challenges.
    Scherliess R
    Ther Deliv; 2011 Oct; 2(10):1351-68. PubMed ID: 22826888
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Advances Towards Painless Vaccination and Newer Modes of Vaccine Delivery.
    Garg N; Aggarwal A
    Indian J Pediatr; 2018 Feb; 85(2):132-138. PubMed ID: 28620730
    [TBL] [Abstract][Full Text] [Related]  

  • 84. New vaccine technology--what do you need to know?
    Minichiello V
    J Am Acad Nurse Pract; 2002 Feb; 14(2):73-81. PubMed ID: 11892539
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Transcutaneous immunization of domestic animals: opportunities and challenges.
    Hammond SA; Tsonis C; Sellins K; Rushlow K; Scharton-Kersten T; Colditz I; Glenn GM
    Adv Drug Deliv Rev; 2000 Sep; 43(1):45-55. PubMed ID: 10967220
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Understanding the basis of transcutaneous vaccine delivery.
    Gamazo C; Pastor Y; Larrañeta E; Berzosa M; Irache JM; Donnelly RF
    Ther Deliv; 2019 Jan; 10(1):63-80. PubMed ID: 30730825
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Transcutaneous immunization and immunostimulant strategies.
    Glenn GM; Kenney RT; Hammond SA; Ellingsworth LR
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):787-813. PubMed ID: 14753392
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Needle-free vaccine delivery.
    Kersten G; Hirschberg H
    Expert Opin Drug Deliv; 2007 Sep; 4(5):459-74. PubMed ID: 17880271
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Ambiguities in the preclinical quality assessment of microparticulate vaccines.
    Johansen P; Gander B; Merkle HP; Sesardic D
    Trends Biotechnol; 2000 May; 18(5):203-11. PubMed ID: 10758515
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Advances in vaccine delivery: transcutaneous immunisation.
    Glenn GM; Scharton-Kersten T; Alving CR
    Expert Opin Investig Drugs; 1999 Jun; 8(6):797-805. PubMed ID: 15992132
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Formulation-based approaches for dermal delivery of vaccines and therapeutic nucleic acids: Recent advances and future perspectives.
    Sallam MA; Prakash S; Kumbhojkar N; Shields CW; Mitragotri S
    Bioeng Transl Med; 2021 Sep; 6(3):e10215. PubMed ID: 34589595
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [The brief history and current application of vaccines].
    Li XD; Li TS
    Zhonghua Nei Ke Za Zhi; 2022 May; 61(5):588-593. PubMed ID: 35488615
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Topical Anti-Nuclear Factor-Kappa B Small Interfering RNA with Functional Peptides Containing Sericin-Based Hydrogel for Atopic Dermatitis.
    Kanazawa T; Shizawa Y; Takeuchi M; Tamano K; Ibaraki H; Seta Y; Takashima Y; Okada H
    Pharmaceutics; 2015 Sep; 7(3):294-304. PubMed ID: 26371030
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses.
    Zaric M; Lyubomska O; Touzelet O; Poux C; Al-Zahrani S; Fay F; Wallace L; Terhorst D; Malissen B; Henri S; Power UF; Scott CJ; Donnelly RF; Kissenpfennig A
    ACS Nano; 2013 Mar; 7(3):2042-55. PubMed ID: 23373658
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles.
    Kim YC; Quan FS; Song JM; Vunnava A; Yoo DG; Park KM; Compans RW; Kang SM; Prausnitz MR
    Procedia Vaccinol; 2010; 2(1):15-19. PubMed ID: 21528098
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune response.
    Eisenberg G; Machlenkin A; Frankenburg S; Mansura A; Pitcovski J; Yefenof E; Peretz T; Lotem M
    Cell Immunol; 2010; 266(1):98-103. PubMed ID: 20947070
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pocketed Microneedles for Drug Delivery to the Skin.
    Gill HS; Prausnitz MR
    J Phys Chem Solids; 2008 May; 69(5-6):1537-1541. PubMed ID: 20648232
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.
    Flacher V; Sparber F; Tripp CH; Romani N; Stoitzner P
    Cancer Immunol Immunother; 2009 Jul; 58(7):1137-47. PubMed ID: 18677477
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Temperature-induced protein release from water-in-oil-in-water double emulsions.
    Rojas EC; Staton JA; John VT; Papadopoulos KD
    Langmuir; 2008 Jul; 24(14):7154-60. PubMed ID: 18543998
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Enhanced skin penetration of P20 phosphopeptide using protein transduction domains.
    Lopes LB; Furnish E; Komalavilas P; Seal BL; Panitch A; Bentley MV; Brophy CM
    Eur J Pharm Biopharm; 2008 Feb; 68(2):441-5. PubMed ID: 18035527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.